Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Active virosome vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : The Union science and technology ministry of India
Deal Size : Undisclosed
Deal Type : Funding
Pune Firm First in India to Get Govt Funding for COVID-19 Vaccine
Details : The Union science and technology ministry will fund Seagull Biosolutions to develop a vaccine for Covid-19 which is expected to enter phase-1 trial in 18-20 months.
Brand Name : Undisclosed
Molecule Type : Vaccine
Upfront Cash : Undisclosed
April 12, 2020
Lead Product(s) : Active virosome vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : The Union science and technology ministry of India
Deal Size : Undisclosed
Deal Type : Funding
LOOKING FOR A SUPPLIER?